Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (19 ops.)
Latest filing published 05 Nov 2025 for Maze Therapeutics, Inc.. Read the official filing
Filing timeline
BuySaleThird Rock Ventures IV, L.P.
Insider track record
Disclosed buys
0
Disclosed sells
19
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Third Rock Ventures IV, L.P.: trading record in brief
Filings by Third Rock Ventures IV, L.P. span 3 companies, the busiest being Tango Therapeutics, Inc., Dianthus Therapeutics, Inc. /DE/ and Maze Therapeutics, Inc. Between 25 August 2021 and 4 November 2025, the trades on record add up to 22 filings.
The open-market record consists of 19 sales worth €42.4M, with no purchase. So far in 2025, the count stands at no purchases and 6 sales.
Most recently, on 5 November 2025, the filings show a transaction in Maze Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Third Rock Ventures IV, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations22 total
1,600,000 sharesCommon StockSEC:0001193125-25-266981:0
477,401 shares@ US$10.15210.2% of flowCommon StockSEC:0001193125-25-251606:0
500,000 shares@ US$8.0179.4% of flowCommon StockSEC:0001193125-25-223227:0
363,541 shares@ US$7.046.5% of flowCommon StockSEC:0001193125-25-206453:0
642,906 shares@ US$7.0012.5% of flowCommon StockSEC:0001193125-25-199177:0
302,194 shares@ US$7.006.7% of flowCommon StockSEC:0000950170-25-111457:0
1,100,000 shares@ US$7.011624.4% of flowCommon StockSEC:0000950170-25-110662:0
5,762,788 shares0Common StockSEC:0000950170-25-013760:0
67,400 shares@ US$10.53053.4% of flowCommon StockSEC:0000950170-24-107330:0
75,000 shares@ US$11.56184.2% of flowCommon StockSEC:0000950170-24-104863:0
175,000 shares@ US$11.59839.8% of flowCommon StockSEC:0000950170-24-103661:0
25,000 shares@ US$11.54661.4% of flowCommon StockSEC:0000950170-24-101910:0
135,000 shares@ US$9.78856.5% of flowCommon StockSEC:0000950170-24-099253:0
95,000 shares@ US$9.80124.6% of flowCommon StockSEC:0000950170-24-089474:0
50,000 shares@ US$9.8392.4% of flowCommon StockSEC:0000950170-24-087862:0
200,000 shares@ US$9.81589.7% of flowCommon StockSEC:0000950170-24-086894:0
262,740 shares@ US$9.781912.6% of flowCommon StockSEC:0000950170-24-086051:0
191,490 shares@ US$9.80989.2% of flowCommon StockSEC:0000950170-24-085256:0
550,171 shares@ US$9.790326.4% of flowCommon StockSEC:0000950170-24-084580:0
162,500 shares@ US$12.009.7% of flowCommon StockSEC:0000950170-24-018198:0
2,200,000 shares@ US$0.83100.0% of flowCommon StockSEC:0000899243-23-004411:0
1,250,000 sharesCommon StockSEC:0000899243-21-034297:0
22 of 22 declarations
